Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


13.01.2025

13 AIDS
3 AIDS Res Hum Retroviruses
1 BMC Immunol
1 BMJ
1 Br J Haematol
2 Clin Infect Dis
1 HIV Med
15 J Acquir Immune Defic Syndr
1 J Med Virol
3 N Engl J Med
1 Pediatr Infect Dis J
18 PLoS One
2 PLoS Pathog
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. POURCHER V, Robineau O, Parienti JJ, Loubet P, et al
    Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France.
    AIDS. 2025 Jan 10. doi: 10.1097/QAD.0000000000004118.
    PubMed         Abstract available

  2. DIEZ-VIDAL A, Gil-Garrote S, Diaz-Pollan B, Rodriguez-Sevilla G, et al
    Amebic liver abscess presenting in a nonendemic region after a 12-year latency in a patient with well controlled HIV infection.
    AIDS. 2025;39:211-213.
    PubMed        

  3. BOWLER SA, Premeaux TA, Ratzan L, Friday C, et al
    Plasma anti-CD4 IgG levels are associated with poor immune recovery in people with HIV initiating antiretroviral therapy.
    AIDS. 2025;39:208-210.
    PubMed         Abstract available

  4. GONZALEZ-SCARANO F, Kolson DL
    Imaging brain inflammation in virally suppressed people with HIV-1.
    AIDS. 2025;39:204-205.
    PubMed        

  5. TAVASOLI A, Okwuegbuna OK, Tang B, Iudicello JE, et al
    Hepcidin modifies the relationship between anemia, erythrocyte indices, and neurocognitive performance in virally suppressed people with HIV.
    AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004110.
    PubMed         Abstract available

  6. CASSIDY AR, Mayondi G, Williams PL, Moabi K, et al
    Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based ART.
    AIDS. 2025 Jan 6. doi: 10.1097/QAD.0000000000004111.
    PubMed         Abstract available

  7. HIDALGO-TENORIO C, Calle-Gomez I, Moya R, Omar M, et al
    Prevalence and incidence of HPV-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people living with HIV (PLHIV).
    AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004113.
    PubMed         Abstract available

  8. GUPTA SK, Friedman AN, Desta Z
    The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis.
    AIDS. 2024 Nov 25. doi: 10.1097/QAD.0000000000004071.
    PubMed         Abstract available

  9. YAN LD, Rouzier V, Sufra R, Sauveur RST, et al
    Treatment of prehypertension among adults with HIV: a randomized clinical trial.
    AIDS. 2024 Nov 14. doi: 10.1097/QAD.0000000000004065.
    PubMed         Abstract available

  10. VYAS KJ, Marconi VC, Agan BK, Sullivan PS, et al
    Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004105.
    PubMed         Abstract available

  11. BOERING P, Murray C, Portwood C, Hey M, et al
    Perinatal outcomes among pregnant women living with HIV initiating antiretroviral therapy preconception and antenatally: systematic review and meta-analysis.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004104.
    PubMed         Abstract available

  12. MULINGE MM, Kimani H, Inziani M, Bwana P, et al
    Trends and factors associated with HIV viral load non-suppression among treatment-experienced female sex workers in Kenya: a retrospective cohort study.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004102.
    PubMed         Abstract available

  13. WILLIAMS ME, Asia LK, Lindeque Z, Van Vuren EJ, et al
    The relationship between immune markers and tryptophan-kynurenine metabolites in South African people with HIV.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004103.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  14. CHEN M, Chen H, Dai J, Dong L, et al
    Characterization of an Invisible HIV-1 Circulating Recombinant Form (CRF149_01B) in China.
    AIDS Res Hum Retroviruses. 2025 Jan 8. doi: 10.1089/aid.2024.0099.
    PubMed         Abstract available

  15. GUAN Y, Wang J, Liu M, Lu X, et al
    Confirmation of Two Novel HIV-1 CRF01_AE/CRF07_BC Recombinant Forms Among Men Who Have Sex with Men in Hebei, China.
    AIDS Res Hum Retroviruses. 2025 Jan 8. doi: 10.1089/aid.2024.0104.
    PubMed         Abstract available

  16. HIJONA ELOSEGUI JJ, Carballo Garcia AL, Fernandez Risquez AC, Presa Lorite JC, et al
    Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV.
    AIDS Res Hum Retroviruses. 2025 Jan 8. doi: 10.1089/aid.2024.0067.
    PubMed         Abstract available


    BMC Immunol

  17. RAHMOUNI M, Clerc SL, Spadoni JL, Labib T, et al
    Deep analysis of the major histocompatibility complex genetic associations using covariate analysis and haploblocks unravels new mechanisms for the molecular etiology of Elite Control in AIDS.
    BMC Immunol. 2025;26:1.
    PubMed         Abstract available


    BMJ

  18. THOMSON-GLOVER R
    Tools to assist identification of child abuse, neglect, and exploitation.
    BMJ. 2025;388:r26.
    PubMed        


    Br J Haematol

  19. GE S, Ali S, Haldane V, Bekdache C, et al
    An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low- to middle-income countries.
    Br J Haematol. 2025 Jan 6. doi: 10.1111/bjh.19984.
    PubMed         Abstract available


    Clin Infect Dis

  20. MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
    Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
    Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
    PubMed         Abstract available


  21. Correction to: Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon.
    Clin Infect Dis. 2025 Jan 7:ciaf001. doi: 10.1093.
    PubMed        


    HIV Med

  22. WALKER SH, Grierson J, Sullivan A, Alagaratnam J, et al
    The effects of the COVID-19 pandemic on people living with HIV.
    HIV Med. 2025 Jan 6. doi: 10.1111/hiv.13754.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  23. TESORIERO JM, Boos EM, Adamashvili N, Massaroni R, et al
    Assessing Gaps in Integrated HIV and STI Testing Among New York State-Funded Providers by Pre-Exposure Prophylaxis Status: Implications for Status-Neutral Programming.
    J Acquir Immune Defic Syndr. 2025 Jan 6. doi: 10.1097/QAI.0000000000003598.
    PubMed         Abstract available

  24. JONES J, Siegler AJ, Glick JL, Lucas I, et al
    Potential gains in PrEP coverage and effect on racial disparities following introduction of on-demand and long-acting injectable PrEP: Preferences of men who have sex with men in the United States, 2021-2022.
    J Acquir Immune Defic Syndr. 2025 Jan 9. doi: 10.1097/QAI.0000000000003602.
    PubMed         Abstract available

  25. CHAN PA, Goedel WC, Li Y, Mena L, et al
    Impact of Social Determinants of Health on Pre-exposure Prophylaxis Care for HIV Prevention.
    J Acquir Immune Defic Syndr. 2025 Jan 9. doi: 10.1097/QAI.0000000000003601.
    PubMed         Abstract available

  26. MARCUS R, Dasgupta S, Taussig J, Tie Y, et al
    Social Determinants of Health and Unmet Needs for Services among Young Adults with HIV: Medical Monitoring Project, 2018-2021.
    J Acquir Immune Defic Syndr. 2025 Jan 9. doi: 10.1097/QAI.0000000000003605.
    PubMed         Abstract available

  27. CARBONE A, Vaccher E, Gloghini A, Pria AD, et al
    Management of KSHV/HHV8 positive Multicentric Castleman Disease concurrent with other KSHV/HHV8 positive disorders. An emergent challenge in PLWH.
    J Acquir Immune Defic Syndr. 2025 Jan 9. doi: 10.1097/QAI.0000000000003604.
    PubMed        

  28. SONG W, Mulatu MS, Crepaz N, Wang G, et al
    Association Between County-Level Social Vulnerability and CDC-funded HIV Testing Program Outcomes in the United States, 2020-2022.
    J Acquir Immune Defic Syndr. 2025 Jan 9. doi: 10.1097/QAI.0000000000003603.
    PubMed         Abstract available

  29. MAYA S, Sheira LA, Frongillo EA, Pala AN, et al
    Brief Report: Internalized Poverty-Related Stigma and Interpersonal Violence Among Women Living With HIV in the United States.
    J Acquir Immune Defic Syndr. 2025;98:99-102.
    PubMed         Abstract available

  30. TASSIOPOULOS K, John B, Khadraoui A, Salomon L, et al
    Brief Report: Transition Preparation and Post-Transition Evaluation Practices at Adult Clinics That Care for Young Adults With Perinatally Acquired HIV in Massachusetts, United States.
    J Acquir Immune Defic Syndr. 2025;98:103-107.
    PubMed         Abstract available

  31. DOMINGUEZ-DOMINGUEZ L, Hamzah L, Fox J, Vincent RP, et al
    Brief Report: Cystatin C Provides Substantially Higher Glomerular Filtration Rate Estimates Than Creatinine in a Subset of Black People With HIV on Current Antiretroviral Regimens.
    J Acquir Immune Defic Syndr. 2025;98:171-175.
    PubMed         Abstract available

  32. SPINELLI MA, Christopoulos KA
    Reply.
    J Acquir Immune Defic Syndr. 2025;98:e12.
    PubMed        

  33. KRENISKE P, Nalugoda F, Chen I, Parate N, et al
    Brief Report: Antiretroviral Treatment Use Over Time Among Adolescents and Young Adults in the Rakai Community Cohort Study, 2011-2020.
    J Acquir Immune Defic Syndr. 2024;97:433-438.
    PubMed         Abstract available

  34. PAINE EA, Appenroth M, Scheim A, Goldrich M, et al
    Brief Report:Availability of and Interest in Gender-Affirming Care, PrEP, and HIV Prevention Services in a Global Sample of Transmasculine Persons.
    J Acquir Immune Defic Syndr. 2024;97:471-476.
    PubMed         Abstract available

  35. HASTIE E, Srivatsa MS, Gianella S, Cottrell M, et al
    Brief Report: Genital Microbiome, Inflammation, and Tenofovir Levels in Transgender Men and Cisgender Women Taking Oral PrEP.
    J Acquir Immune Defic Syndr. 2024;97:477-481.
    PubMed         Abstract available


  36. Early Efficacy and Safety of the Third Dose Inactivated COVID-19 Vaccine Among People Living With HIV: Erratum.
    J Acquir Immune Defic Syndr. 2024;97:e30.
    PubMed        

  37. THORP M, Phiri S, Phiri K, Robson I, et al
    Brief Report: Stated Preferences for Long-Acting Injectable ART Among Mobile Men Living With HIV in Malawi: A Qualitative Study.
    J Acquir Immune Defic Syndr. 2024;97:e25-e29.
    PubMed         Abstract available


    J Med Virol

  38. XIAO Q, He S, Wang C, Liu Y, et al
    Urgent Call for Attention to HIV-Associated Lymphoma: After AIDS 2024, the 25th International AIDS Conference.
    J Med Virol. 2025;97:e70159.
    PubMed        


    N Engl J Med

  39. DURAND CM, Segev DL, Redd AD
    Safety of Kidney Transplantation from Donors with HIV Infection. Reply.
    N Engl J Med. 2025;392:204-205.
    PubMed        

  40. CHEN T, Shang G
    Safety of Kidney Transplantation from Donors with HIV Infection.
    N Engl J Med. 2025;392:204.
    PubMed        

  41. HOU J, Zhang W, Xie Q, Hua R, et al
    Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.
    N Engl J Med. 2024;391:2098-2109.
    PubMed         Abstract available


    Pediatr Infect Dis J

  42. MUNOZ FM, Beigi R, Posavad CM, Kelly C, et al
    Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
    Pediatr Infect Dis J. 2024;43:1065-1073.
    PubMed         Abstract available


    PLoS One

  43. KITOKI S, Seif SA, Masika GM
    Examining the moderating effects of biopsychosocial factors on the relationship between HIV-related depression and cognitive function among adolescents living with HIV in Tanzania: A protocol for an analytical cross-sectional study.
    PLoS One. 2025;20:e0313223.
    PubMed         Abstract available

  44. ALEMU GG, Yirsaw BG, Tesfie TK, Yismaw GA, et al
    Adherence to antiretroviral therapy and its associated factors among children living with HIV in Eastern and Southern Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0312529.
    PubMed         Abstract available

  45. KOOLE JCD, Bedert MRD, de la Court F, Bais I, et al
    Barriers and missed opportunities in PrEP uptake, use and care among men who have sex with men with recent HIV infection in the Netherlands.
    PLoS One. 2025;20:e0310621.
    PubMed         Abstract available

  46. MOHOLOLA M, Rees K, Motsoane N, Kgopong N, et al
    Effect of case management on viral load in adult clients enrolled due to non-suppression in Capricorn District, South Africa: A case control study.
    PLoS One. 2025;20:e0317015.
    PubMed         Abstract available

  47. WONDIE WT, Wubneh CA, Legesse BT, Mekonen GB, et al
    Mortality and predictors among HIV-TB co-infected patients in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317048.
    PubMed         Abstract available

  48. VALLEJOS PARAS A, Arriaga Nieto L, Cabrera Gaytan DA, Cacho Diaz B, et al
    Risk factors for human infection with mpox among the Mexican population with social security.
    PLoS One. 2025;20:e0313691.
    PubMed         Abstract available

  49. YOKOMAKU Y, Teruya K, Watanabe D, Endo T, et al
    Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naive and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort.
    PLoS One. 2025;20:e0313338.
    PubMed         Abstract available

  50. ALTAF A, Pasha MSK, Majeed A, Ali W, et al
    Correction: Acceptability and feasibility of HIV self-testing among transgender people in Larkana, Pakistan: Results from a pilot project.
    PLoS One. 2024;19:e0316739.
    PubMed         Abstract available

  51. MWAKILASA MT, Mwijage A, Mushy S, Amour M, et al
    "They are not HIV treatments drugs; they are preventive drugs (PrEP)". Experiences of PrEP uptake among vulnerable adolescent girls and young women in Tanzania.
    PLoS One. 2025;20:e0313501.
    PubMed         Abstract available

  52. OCHOLA EA, Mweu MM
    Performance of three diagnostic tests for tuberculosis among Human Immunodeficiency Virus (HIV) patients presenting to a health facility in an informal urban settlement in Nairobi, Kenya.
    PLoS One. 2024;19:e0307727.
    PubMed         Abstract available

  53. MALINDISA EK, Dika H, Rehman AM, Kweka B, et al
    Associations between dietary patterns and intestinal inflammation among HIV-infected and uninfected adults: A cross-sectional study in Tanzania.
    PLoS One. 2024;19:e0311693.
    PubMed         Abstract available


  54. Correction: Correction: HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis.
    PLoS One. 2024;19:e0316768.
    PubMed         Abstract available

  55. NWOKOYE N, Ihesie A, Olabamiji J, Ochei K, et al
    Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study.
    PLoS One. 2024;19:e0316204.
    PubMed         Abstract available

  56. KIRAGGA AN, Onzia A, Nakate V, Bagaya I, et al
    Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa.
    PLoS One. 2024;19:e0315191.
    PubMed         Abstract available

  57. GUADIE BA, Belete MB, Beyene MM, Melese AK, et al
    The experience of living with human immunodeficiency virus among adolescents at Felege Hiwot Comprehensive Specialized Hospital Bahir-Dar, Northwest Ethiopia, A phenomenological study.
    PLoS One. 2025;20:e0308347.
    PubMed         Abstract available

  58. FRAYSSE J, Anderson SJ, Smith JC, Matthews DD, et al
    Achieving the state of Georgia 25% HIV incidence reduction target among men who have sex with men in Atlanta through expanded use of multimodal pre-exposure prophylaxis: A mathematical model.
    PLoS One. 2025;20:e0312369.
    PubMed         Abstract available

  59. DYER CEF, Jin F, Roberts JM, Poynten IM, et al
    Self- versus clinician-collected swabs in anal cancer screening: A clinical trial.
    PLoS One. 2025;20:e0312781.
    PubMed         Abstract available

  60. MUPAMBIREYI Z, Simms V, Mavhu W, Mutasa C, et al
    Clinical and psychosocial context of HIV perinatally infected young mothers in Harare, Zimbabwe: A longitudinal mixed-methods study.
    PLoS One. 2025;20:e0315299.
    PubMed         Abstract available


    PLoS Pathog

  61. FARINRE O, Anaya T, King AC, Endrias K, et al
    SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
    PLoS Pathog. 2025;21:e1012863.
    PubMed         Abstract available

  62. MAN S, Jansen J, Kroeze S, Geijtenbeek TBH, et al
    Transcriptomic HIV-1 reservoir profiling reveals a role for mitochondrial functionality in HIV-1 latency.
    PLoS Pathog. 2025;21:e1012822.
    PubMed         Abstract available


    Virology

  63. GAIKWAD SY, More A, Seniya C, Verma K, et al
    Synergistic inhibition of HIV-1 by Nelfinavir and Epigallocatechin Gallate: A novel nanoemulsion-based therapeutic approach.
    Virology. 2025;603:110391.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.